Showing 101 - 120 results of 24,933 for search '(((( a large decrease ) OR ( ((b large) OR (i large)) decrease ))) OR ( a larger increases ))', query time: 1.19s Refine Results
  1. 101
  2. 102
  3. 103
  4. 104
  5. 105

    DataSheet_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx by Boram Lee (549836)

    Published 2021
    “…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”
  6. 106

    Norm ISWSVR: A Data Integration and Normalization Approach for Large-Scale Metabolomics by Xian Ding (421647)

    Published 2022
    “…More importantly, Norm ISWSVR also allows a low frequency of QCs, which could significantly decrease the burden of a large-scale experiment. …”
  7. 107
  8. 108
  9. 109
  10. 110
  11. 111
  12. 112

    Table1_A Multicenter Study of 239 Patients Aged Over 70 Years With Diffuse Large B-Cell Lymphoma in China.docx by Chunli Yang (2087218)

    Published 2022
    “…Additionally, in the 70–80-year group, reduction in chemotherapy dose was associated with a significantly shorter OS, with a 2-year OS rate of 74.4% in the full dose group, compared to 67.1% for the decreased-dose group (p = 0.044).…”
  13. 113

    DataSheet1_Adverse childhood experiences, brain function, and psychiatric diagnoses in a large adult clinical cohort.pdf by David B. Keator (19842939)

    Published 2024
    “…However, no study has explored these associations in a large clinical population to identify brain regions that may mediate the relationship between ACEs and psychiatric diagnoses. …”
  14. 114

    Table 1_Association of dynamic changes in metabolic syndrome components with clinical outcomes in diffuse large B-cell lymphoma.docx by Dewan Zhao (21547445)

    Published 2025
    “…Introduction<p>Diffuse Large B-Cell Lymphoma (DLBCL) is the most common subtype of Non-Hodgkin Lymphoma (NHL), with 20-40% of patients experiencing poor outcomes despite advancements in treatment. …”
  15. 115
  16. 116
  17. 117
  18. 118
  19. 119
  20. 120